Skip to main content
. 2003 Mar;41(3):1332–1336. doi: 10.1128/JCM.41.3.1332-1336.2003

TABLE 1.

Antifungal susceptibilities of the two clinical isolates of Phaeoacremonium spp.

Isolateb MICa (μg/ml)
AMB FCZ ITRZ KCZ RCZ TF VCZ
P. aleophilum FMR 7682 2 8 >16 4 1 2 1
P. rubrigenum FMR 7681 2 8 8 2 0.5 2 1
a

AMB, amphotericin B; FCZ, fluconazole; ITRA, itraconazole; KCZ, ketoconazole; RCZ, ravuconazole; TF, terbinafine; VCZ, voriconazole.

b

FMR, Faculty of Medicine in Reus, Spain.